Firibastat, (originally named QGC001) is the first drug candidate of a new class of centrally acting antihypertensive agents, brain APA inhibitors. Firibastat acts as an antihypertensive drug and not as a hypotensive agent.
For research use only. We do not sell to patients.
| Name | Firibastat ( QGC-001 ) |
|---|---|
| Iupac Chemical Name | (S)-3-amino-4-(((S)-2-amino-4-sulfobutyl)disulfaneyl)butane-1-sulfonic acid |
| Synonyms | RB-150 ; QGC-001 ; RB150 ; QGC001 ; RB 150 ; QGC 001 ; Firibastat |
| Molecular Formula | C8H20N2O6S4 |
| Molecular Weight | 368.51 |
| Smile | O=S(CC[C@H](N)CSSC[C@@H](N)CCS(=O)(O)=O)(O)=O |
| InChiKey | HJPXZXVKLGEMGP-YUMQZZPRSA-N |
| InChi | InChI=1S/C8H20N2O6S4/c9-7(1-3-19(11,12)13)5-17-18-6-8(10)2-4-20(14,15)16/h7-8H,1-6,9-10H2,(H,11,12,13)(H,14,15,16)/t7-,8-/m0/s1 |
| CAS Number | 648927-86-0 |
| Related CAS | 648927-86-0 |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid to white solid |
|---|---|
| Purity | ≧98.0% |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO, water |
| Handling | Avoid inhalation, contact with eyes and skin. Avoid dust and aerosol formation. Use only in areas with appropriate exhaust ventilation. |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |